|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-8-22
|
|
pubmed:abstractText |
We sought to assess the effects of raloxifene, a selective estrogen receptor modulator, on arterial physiology and biology in postmenopausal women with coronary artery disease (CAD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
698-704
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12932604-Aged,
pubmed-meshheading:12932604-Biological Markers,
pubmed-meshheading:12932604-Coronary Artery Disease,
pubmed-meshheading:12932604-Coronary Vessels,
pubmed-meshheading:12932604-Cross-Over Studies,
pubmed-meshheading:12932604-Double-Blind Method,
pubmed-meshheading:12932604-Endothelin-1,
pubmed-meshheading:12932604-Endothelium, Vascular,
pubmed-meshheading:12932604-Female,
pubmed-meshheading:12932604-Fibrinogen,
pubmed-meshheading:12932604-Humans,
pubmed-meshheading:12932604-Lipoproteins,
pubmed-meshheading:12932604-Middle Aged,
pubmed-meshheading:12932604-Postmenopause,
pubmed-meshheading:12932604-Prospective Studies,
pubmed-meshheading:12932604-Prostaglandins,
pubmed-meshheading:12932604-Raloxifene,
pubmed-meshheading:12932604-Selective Estrogen Receptor Modulators,
pubmed-meshheading:12932604-Vasodilation
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
|
|
pubmed:affiliation |
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
